Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis

Published:2018 Issue:2 Volume:2 Page:
ISSN:2514-1775
Container-title:Rheumatology Advances in Practice
language:en
Short-container-title:

Author:

Massolino Rose I¹,Hissaria Pravin¹²,Lee Anita¹³,Proudman Susanna M¹³

Affiliation:

1. Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia

2. Department of Clinical Immunology, Royal Adelaide Hospital, Adelaide, South Australia, Australia

3. Rheumatology Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

http://academic.oup.com/rheumap/article-pdf/2/2/rky029/28865962/rky029.pdf

Reference6 articles.

1. Drug reaction with eosinophilia and systemic symptoms: a drug-induced hypersensitivity syndrome with variable clinical features;Chen;Dermatol Sin,2013

2. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response;Picard;Sci Transl Med,2010

3. Association of human herpes virus 6 infection with drug reaction with eosinophilia and systemic symptoms;Descamps;Arch Dermatol,2001

4. Short course of tocilizumab increases risk of hepatitis B virus (HBV) reactivation in patients with rheumatoid arthritis: a real-world, prospective cohort study;Chen;Ann Rheum Dis,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and prospects of IL-6–targeting therapy;Expert Review of Clinical Pharmacology;2022-05-04

2. Tocilizumab and its usage for skin diseases;Italian Journal of Dermatology and Venereology;2022-02

3. Cutaneous Adverse Reactions to Biologic Agents;Drug Eruptions;2022

4. ‘Toxic erythema’ and eosinophilia associated with tocilizumab therapy in a COVID‐19 patient;Journal of the European Academy of Dermatology and Venereology;2020-06-08

5. Tocilizumab;Reactions Weekly;2019-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3